Page 15 - Read Online

Chen et al. Rare Dis Orphan Drugs J 2022;1:15 https://dx.doi.org/10.20517/rdodj.2022.18 Page 11 of 12

37. Newby PR, Crossley D, Crisford H, et al. A specific proteinase 3 activity footprint in α(1)-antitrypsin deficiency. ERJ Open Res
2019;5:00095-2019. DOI PubMed PMC
38. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-
induced emphysema in mice. Am J Pathol 2003;163:2329-35. DOI PubMed PMC
39. Cepinskas G, Sandig M, Kvietys PR. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the
mobilization of elastase to the neutrophil surface and localization to the migrating front. J Cell Sci 1999;112:1937-45. DOI PubMed
40. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ. Cell surface-bound elastase and cathepsin G on human neutrophils:
a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol
1995;131:775-89. DOI PubMed PMC
41. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in alpha 1-antitrypsin
deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991;88:891-7. DOI PubMed PMC
42. Walsh DE, Greene CM, Tomás PC, et al. Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in
human bronchial epithelium. J Biol Chem 2001;276:35494-9. DOI PubMed
43. Woolhouse IS, Bayley DL, Stockley RA. Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha-1
antitrypsin deficiency and the role of leukotriene B4 and interleukin 8. Thorax 2002;57:709-14. DOI PubMed PMC
44. Gaggar A, Weathington N. Bioactive extracellular matrix fragments in lung health and disease. J Clin Invest 2016;126:3176-84. DOI
PubMed PMC
45. Pittman K, Kubes P. Damage-associated molecular patterns control neutrophil recruitment. J Innate Immun 2013;5:315-23. DOI
PubMed PMC
46. McElvaney NG, Stoller JK, Buist AS, et al. Baseline characteristics of enrollees in the national heart, lung and blood institute registry
of alpha 1-antitrypsin deficiency. alpha 1-antitrypsin deficiency registry study group. Chest 1997;111:394-403. DOI PubMed
47. Liou TG and Campbell EJ. Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative
mechanism of extracellular proteolytic activity. J Immunol 1996;157:2624-31. PubMed
48. Chapman KR, Stockley RA, Dawkins C, Wilkes MM, Navickis RJ. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-
analysis. COPD 2009;6:177-84. DOI PubMed
49. Stockley RA, Edgar RG, Starkey S, Turner AM. Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease
modifying therapies? Respir Res 2018;19:137. DOI PubMed PMC
50. Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in
α(1)-antitrypsin deficiency. Eur Respir J 2017;50:1700610. DOI PubMed
51. Schouten IGM, Kasteleyn MJ, Tsonaka R, et al. Long-term effect of α(1)-antitrypsin augmentation therapy on the decline of FEV(1) in
deficient patients: an analysis of the AIR database. ERJ Open Res 2021;7:00194-2021. DOI
52. Stockley RA. Alpha-1 antitrypsin deficiency: have we got the right proteinase? Chronic Obstr Pulm Dis 2020;7:163-71. DOI
PubMed PMC
53. Silberstein DZ, Karuppanan K, Aung HH, Chen CH, Cross CE, McDonald KA. An oxidation-resistant, recombinant alpha-1
antitrypsin produced in Nicotiana benthamiana. Free Radic Biol Med 2018;120:303-10. DOI PubMed PMC
54. Takeda K, Kim SH, Joetham A, Petrache I, Gelfand EW. Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion
protein in experimental emphysema. Respir Res 2021;22:207. DOI PubMed PMC
55. Inhibrx Inc. Press Release. INBRX-101 shows favorable safety profile in patients with alpha-1 antitrypsin deficiency and demonstrates
potential to achieve normal functional alpha-1 antitrypsin levels with monthly dosing. Available from:
https://www.prnewswire.com/news-releases/inbrx-101-shows-favorable-safety-profile-in-patients-with-alpha-1-antitrypsin-deficiency-
and-demonstrates-potential-to-achieve-normal-functional-alpha-1-antitrypsin-levels-with-monthly-dosing-301547416.html [Last
accessed on 9 Dec 2022].
56. Centessa Press Release. Centessa pharmaceuticals reports financial results and business highlights for the second quarter of 2022;
provides program update for ZF874. Available from: https://investors.centessa.com/news-releases/news-release-details/centessa-
pharmaceuticals-reports-financial-results-and-business [Last accessed on 9 Dec 2022].
57. Vertex Press Release. Vertex announces primary endpoint achieved in phase 2 study of VX-864 in alpha-1 antitrypsin deficiency.
Available from: https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-primary-endpoint-achieved-phase-2-
study-vx-864 [Last accessed on 9 Dec 2022].
58. Stolk J, Tov N, Chapman KR, et al. Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and
frequent exacerbations of COPD. Eur Respir J 2019;54:1900673. DOI PubMed
59. Hubbard RC, Brantly ML, Sellers SE, Mitchell ME, Crystal RG. Anti-neutrophil-elastase defenses of the lower respiratory tract in
alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med 1989;111:206-12. DOI
PubMed
60. Kropp J, Wencker M, Hotze A, et al. Inhalation of 123I alpha1-protease inhibitor: toward a new therapeutic concept of alpha1-protease
inhibitor deficiency? J Nucl Med 2001;42:744-51. PubMed
61. Sullivan AL, Dafforn T, Hiemstra PS, Stockley RA. Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI)
by lung epithelial cells: role of charge of the proteinase-inhibitor complex. Respir Res 2008;9:60. DOI PubMed PMC
62. Bruch M, Bieth JG. Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor.
Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem J 1986;238:269-73. DOI PubMed PMC